Skip to main content
finq
OS
Search ticker, company, or fund...
⌘
K
Capture
Closed
DARE: Dare Bioscience, Inc. Stock Analysis | finqOS
Healthcare · Biotechnology
The Story
DARE
The Story
DARE
Loading chart data...
Current State
Balance holding
The verdict
Good business
Weak
Operating margin
-1034.4%
ROIC
-151.4%
Financially safe
Stretched
Debt / equity
2.20×
Interest coverage
-25.6×
Current ratio
1.03×
Dare Bioscience, Inc.
DARE
NASDAQ
·
USD
·
Closed
Story
Data
Canvas
Capture
Save
Dare Bioscience, Inc.
DARE
NASDAQ
·
USD
·
Closed
$1.22
−1.61%
$1.22
−$0.02 (1.61%)
52W Range
3th
pctl
Volume
0.18×
avg
Mkt Cap
11.62M
USD
P/E
-1.2
TTM
Div Yield
–
ann
52W Range
3th
pctl
Volume
0.18×
avg
Market Cap
11.62M
USD
P/E Ratio
-1.2
TTM
Div Yield
-
ann
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings